23129738Attar EC, Johnson JL, Amrein PC, Lozanski G, Wadleigh M, DeAngelo DJ, Kolitz JE, Powell BL, Voorhees P, Wang ES, Blum W, Stone RM, Marcucci G, Bloomfield CD, Moser B, Larson RAJournal of clinical oncology : official journal of the American Society of Clinical OncologyAntineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; Induction Chemotherapy; Leukemia, Myeloid, AcuteAged; Antigens, Differentiation, B-Lymphocyte; Boronic Acids; Bortezomib; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Drug Synergism; Female; Follow-Up Studies; Histocompatibility Antigens Class II; Humans; Male; Middle Aged; Peripheral Nervous System; Pyrazines; Remission Induction; Survival Analysis; Treatment OutcomeBortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502. J Clin Oncol. 2013 Mar 01; 31(7):923-9.J Clin Oncol2012-11-05T00:00:002012Bortezomib added to daunorubicin and cytarabine during induction therapy and to intermediate-dose cytarabine for consolidation in patients with previously untreated acute myeloid leukemia age 60 to 75 years: CALGB (Alliance) study 10502.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000368Living Beings1341183530.29479AgedD000971Procedures30624340.47627Antineoplastic Combined Chemotherapy ProtocolsD000944Chemicals & Drugs12190.995427Antigens, Differentiation, B-LymphocyteD000949Chemicals & Drugs731580.928374Histocompatibility Antigens Class IID001897Chemicals & Drugs28540.970536Boronic AcidsD004357Physiology1533030.932438Drug SynergismD003630Chemicals & Drugs23780.969479DaunorubicinD003561Chemicals & Drugs512180.932222CytarabineD008875Concepts & IdeasLiving Beings1473249570.258834Middle AgedD005260Physiology1992444050.191184FemaleD011719Chemicals & Drugs39840.950285PyrazinesD006801Living Beings2262862810.130064HumansD008297Physiology1931408600.201635MaleMedicine-Hematology and OncologyD015470Disorders1227550.629278Leukemia, Myeloid, AcuteD016896Concepts & Ideas101179490.402421Treatment OutcomeD016019Concepts & Ideas43415360.742939Survival AnalysisD060828Procedures541470.908423Induction ChemotherapyD060830Procedures12220.984801Consolidation ChemotherapyD00006928630750.970221BortezomibD004334Concepts & Ideas2609160.852436Drug Administration ScheduleD005500Procedures76836160.590143Follow-Up StudiesD012074Procedures1657220.853042Remission InductionD017933Anatomy18210.987907Peripheral Nervous SystemD018572Concepts & Ideas25812030.792724Disease-Free SurvivalUniversity of ChicagoRichard A.LarsonRichard A. Larson41.78927490000000-87.601250000000001169Larson, Richard A.Professortrue1ProfessorProfessorAuthorship 60551160.4539190.4539191authors10.2524has subject area